Essex Investment Management’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-35,361
| Closed | -$1.79M | – | 362 |
|
|
2016
Q3 | $1.79M | Buy |
35,361
+22,234
| +169% | +$1.13M | 0.29% | 91 |
|
|
2016
Q2 | $597K | Sell |
13,127
-1,319
| -9% | -$60K | 0.1% | 215 |
|
|
2016
Q1 | $571K | Buy |
14,446
+1,635
| +13% | +$64.6K | 0.1% | 208 |
|
|
2015
Q4 | $725K | Sell |
12,811
-2,437
| -16% | -$138K | 0.11% | 196 |
|
|
2015
Q3 | $607K | Buy |
+15,248
| New | +$607K | 0.1% | 206 |
|